Tim Sangster is a well travelled bioanalytical chemist having worked in Scotland, Italy, England, America and finally back to Scotland to head up the Bioanalysis and Immunology Department for Charles River, Edinburgh eight years ago. During his travels he has gained experience in both CROs and Pharma supporting drug development from a Bioanalytical perspective from Discovery through to market.
Currently Tim’s main scientific focus are in the use of microsampling to reduce and refine toxicology study designs as well as applying it to other application areas and also the use of LC-MS in the analysis of macromolecules.
What three things would you take if you were stranded on a desert island?
- Pictures of my family (as would prefer they were safe at home)
- a pile of books
- a large sword (protection, tool and hunting)
If you weren’t a bioanalyst, what would you be?
- Would love to have been an actor.
What is your favorite city?
Why have you decided to become a Zone Leader?
Always keen to be involved in industry discussions so I can learn from my colleagues and to help shape our future.
- The current skills gaps in analytical sciences are failing industry: debate at the 21st International Reid Bioanalytical Forum
- Interview with Tim Sangster at EBF 2016
- Exploring microsampling
EBF addresses… the future of the regulatory framework in bioanalysis
EBF addresses… the future challenges and opportunites in biomarkers
EBF addresses… the evolving relationship between CRO and pharm
- Microsampling: where are we now?
Ask the Expert on Microsampling
Back to Zone Leaders